Effects of Pharmacological Suppression of Plasminogen Activator Inhibitor-1 in Myocardial Remodeling After Ischemia Reperfusion Injury

Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men

(2010) M. E. Meltzer et al.   BLOOD

Clarithromycin attenuates myocardial ischemia–reperfusion injury

(2010) Takuya Nakajima et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The Effects of Pharmacologic Plasminogen Activator Inhibitor-1 Inhibition in Acute and Chronic Rejection in Murine Cardiac Allografts

(2010) Masahito Ogawa et al.   TRANSPLANTATION

Cardiac fibroblasts: At the heart of myocardial remodeling

(2009) Karen E. Porter et al.   PHARMACOLOGY & THERAPEUTICS

The Relationship of Plasminogen Activator Inhibitor-1 Levels to the ST Deviation Pattern of Acute Myocardial Infarction

(2008) David Rott et al.   CARDIOLOGY

Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury

(2008) Keiichi Hishikari et al.   CARDIOVASCULAR RESEARCH

A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration

(2008) Shin Wakatsuki et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

A specific inhibitor of plasminogen activator inhibitor-1 suppresses rat autoimmune myocarditis

(2008) Jun-ichi Suzuki et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury

(2008) Jun-ichi Suzuki et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury

(2008) Gavin E Arteel   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis

(2008) Joris J.T.H. Roelofs et al.   KIDNEY INTERNATIONAL

PAI-1 inhibits neutrophil efferocytosis

(2008) Y.-J. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA